Cronos Group: Raymond James Sees US$4.10/Share Valuation Just For Ginkgos Partnership

Raymond James recently upgraded Cronos Group (TSX: CRON) (NASDAQ: CRON) to an Outperform 2 rating as well as almost doubling their price target to C$13.52 / U$10. The justification behind this was that they believe Cronos’ partnership with Ginkgo Bioworks currently adds $1.54 billion or US$4.10 a share in value. After all, Raymond James has created a valuation method specific to cannabinoid biosynthesis.

Raymond James estimates that the global market for products made by cannabinoid biosynthesis will grow from C$10 billion in 2025 to C$115 billion in 2040 with an estimated EBITDA coming in at C$1.3 billion and C$15.2 billion respectively for the sector. Furthermore, its estimated that the present value for the sector is currently ~C$40 billion as a result. The firm says Cronos will begin to see “material revenues for CRON within 12-18 months” from the Ginkgos partnership as a result, although they do not change their revenue estimates for Cronos, which is U$71.5m in revenue with a gross profit of C$35.6m for FY2020.

This updated outlook from Raymond James is noteworthy because with this upgrade they believe there is a ~60% upside to the stock, the highest out of any analyst. With the mean analyst price target being C$8.60, not only is their price target considerably different from their peers but so is their rating, with the firm having an Outperform 2 rating for Cronos, the highest rating Cronos currently has.

There are 12 analysts currently providing a rating, and Raymond has the only outperform rating while only one other firm has a buy rating. The remainder have holds (7) or strong sells (2).


Information for this briefing was found via Sedar, Raymond James and Cronos Group. The author has no securities or affiliations related to these organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Equinox: BMO Lowers Price Target To $15.50 Following Q2 Results

On August 4, Equinox Gold Corp. (TSX: EQX) reported its second quarter production results. The...

Thursday, August 5, 2021, 12:43:00 PM

Cresco Labs: Analysts Raise Targets Following Massachusetts Acquisition

On March 18th, Cresco Labs (CSE: CL) announced the acquisition of Cultivate, a Massachusetts-based vertically...

Tuesday, March 23, 2021, 11:53:00 AM

Cresco Labs: Haywood Marginally Revises Estimates Following Cultivate Acquisition

On September 3, Cresco Labs (CSE: CL) announced that they have closed their acquisition of...

Friday, September 10, 2021, 10:56:00 AM

Cronos Group Appoints Kurt Schmidt As CEO, Gorenstein Appointed Executive Chairman

Cronos GRoup (TSX: CRON) (NASDAQ: CRON) this morning announced that Mike Gorenstein will be stepping...

Wednesday, September 9, 2020, 08:49:18 AM

Stifel-GMP: Canopy Growth CEO’s Legacy is “Poor Execution, Misallocated Capital, and Mismanaged Expectations.”

Earlier this month, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their fiscal second-quarter 2022...

Sunday, November 21, 2021, 12:03:00 PM